Chronic pulsatile infusion of growth hormone to growth-restricted fetal sheep increases circulating fetal insulin-like growth factor-I levels but not fetal growth

被引:23
作者
Bauer, MK [1 ]
Breier, BB [1 ]
Bloomfield, FH [1 ]
Jensen, EC [1 ]
Gluckman, PD [1 ]
Harding, JE [1 ]
机构
[1] Univ Auckland, Fac Med & Hlth Sci, Liggins Inst, Auckland, New Zealand
关键词
D O I
10.1677/joe.0.1770083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intra-uterine growth restriction (IUGR,) is a major cause of perinatal mortality and morbidity. Postnatally, growth hormone (GH) increases growth, increases circulating insulin-like growth factor (IGF)-I levels, and alters metabolism. Our aim was to determine if GH infusion to IUGR fetal sheep would alter fetal growth and metabolism, and thus provide a potential intra-uterine treatment for the IUGR fetus. We studied three groups of fetuses: control, IUGR+ vehicle and IUGR+GH (n=5 all groups). IUGR was induced by repeated embolisation of the placental vascular bed between 110 and 116 days of gestation (term=145 days). GH (3-5 mg/kg/day) or vehicle was infused in a pulsatile manner from 117 to 127 days of gestation. Embolisation reduced fetal growth rate by 25% (P<0(.)01) and reduced the weight of the fetal liver (20%), kidney (23%) and thymus (31%; all P<0(.)05). GH treatment further reduced the weight of the fetal kidneys (32%) and small intestine (35%; both P<0(.)04), but restored the relative weight of the fetal thymus and liver (P<0(.)05). Embolisation decreased fetal plasma IGF-I concentrations (48%, P<0(.)001) and increased IGF binding protein 1 (IGFBP-1) concentrations (737%, P<0(.)002). GH treatment restored fetal plasma IGF-I concentrations to control levels, while levels in IUGR+vehicle fetuses stayed low (P<0(.)05 vs control). IGFBP-1 and IGFBP-2 concentrations were about sevenfold lower in amniotic fluid than in fetal plasma, but amniotic and plasma concentrations were closely correlated (r=0(.)75, P<0(.)0001 and r=0(.)55 P<0(.)0001 respectively). Embolisation transiently decreased fetal blood oxygen content (40%, P<0(.)002), and increased blood lactate cohcentrations (213%, P<0(.)04). Both returned to pre-embolisation levels after embolisation stopped, but blood glucose concentrations declined steadily in IUGR+vehicle fetuses. GH treatment maintained fetal blood glucose concentrations at control levels. Our study shows that GH infusion to the IUGR fetal sheep restores fetal IGF-I levels but does not improve fetal growth, and further reduces the fetal kidney and intestine weights. Thus, fetal GH therapy does not seem a promising treatment stratagem for the IUGR fetus.
引用
收藏
页码:83 / 92
页数:10
相关论文
共 60 条
  • [41] Lee PDK, 1997, P SOC EXP BIOL MED, V216, P319
  • [42] INHIBITORS OF GLUCOSE-UPTAKE STIMULATE THE PRODUCTION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN (IGFBP-1) BY HUMAN FETAL LIVER
    LEWITT, MS
    BAXTER, RC
    [J]. ENDOCRINOLOGY, 1990, 126 (03) : 1527 - 1533
  • [43] MICE CARRYING NULL MUTATIONS OF THE GENES ENCODING INSULIN-LIKE GROWTH FACTOR-I (IGF-1) AND TYPE-1 IGF RECEPTOR (IGF1R)
    LIU, JP
    BAKER, J
    PERKINS, AS
    ROBERTSON, EJ
    EFSTRATIADIS, A
    [J]. CELL, 1993, 75 (01) : 59 - 72
  • [44] MATERNAL INSULIN-LIKE GROWTH-FACTOR-I INFUSION ALTERS FETOPLACENTAL CARBOHYDRATE AND PROTEIN-METABOLISM IN PREGNANT SHEEP
    LIU, L
    HARDING, JE
    EVANS, PC
    GLUCKMAN, PD
    [J]. ENDOCRINOLOGY, 1994, 135 (03) : 895 - 900
  • [45] Insulin-like growth factor I promotes growth selectively in fetal sheep in late gestation
    Lok, F
    Owens, JA
    Mundy, L
    Robinson, JS
    Owens, PC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1996, 270 (05) : R1148 - R1155
  • [46] Growth hormone suppression of insulin-like growth factor binding protein-1 promoter activity
    Lu, XP
    Shi, ZD
    Murphy, LJ
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 149 (1-2) : 19 - 28
  • [47] PROLONGED HYPOXIA INDUCED BY THE REDUCTION OF MATERNAL UTERINE BLOOD-FLOW ALTERS INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 (IGFBP-1) AND IGFBP-2 GENE-EXPRESSION IN THE OVINE FETUS
    MCLELLAN, KC
    HOOPER, SB
    BOCKING, AD
    DELHANTY, PJD
    PHILLIPS, ID
    HILL, DJ
    HAN, VKM
    [J]. ENDOCRINOLOGY, 1992, 131 (04) : 1619 - 1628
  • [48] HYPOPHYSECTOMY OF THE FETAL LAMB LEADS TO A FALL IN THE PLASMA-CONCENTRATION OF INSULIN-LIKE GROWTH FACTOR-I (IGF-I), BUT NOT IGF-II
    MESIANO, S
    YOUNG, IR
    HEY, AW
    BROWNE, CA
    THORBURN, GD
    [J]. ENDOCRINOLOGY, 1989, 124 (03) : 1485 - 1491
  • [49] EFFECT OF HYPOPHYSECTOMY WITH AND WITHOUT THYROXINE REPLACEMENT ON GROWTH AND CIRCULATING CONCENTRATIONS OF INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II IN THE FETAL LAMB
    MESIANO, S
    YOUNG, IR
    BAXTER, RC
    HINTZ, RL
    BROWNE, CA
    THORBURN, GD
    [J]. ENDOCRINOLOGY, 1987, 120 (05) : 1821 - 1830
  • [50] Murphy Liam J., 1995, Progress in Growth Factor Research, V6, P425, DOI 10.1016/0955-2235(95)00026-7